The 7^th World CNS Summit is the only industry-specific conference exclusively focused on advancing translational neurodegenerative research.

World CNS’s mission is to reinvigorate drug discovery and development across multiple neurodegenerative disorders by providing an interactive environment that ensures thought-provoking discussions and unparalleled networking opportunities for all of our attendees, helping to overcome the translational challenges in developing efficacious therapeutics.

Developed in combination with experts from Biogen, Eisai, Merck, AbbVie and other leading organizations, the World CNS Summit uniquely combines distinct neurodegenerative diseases in one setting to examine mechanisms of disease and emerging strategies for targeting.

Following numerous neurodegenerative disease clinical failures, the neurodegenerative disease field requires a refreshed approach towards drug development to drive clinical success.

Now in its 7^th successful year, the World CNS Summit challenges traditional thinking to guide drug development of efficacious treatments for neurodegeneration, bringing together over 150+ leading minds in the neurodegenerative space, from academia, pharma, biotech and leading consortia, to provide a unique opportunity to bridge the gap of translational drug development.

To learn more and to register online, visit http://bit.ly/2AfTc9J